Measurement Periods. Effective Date Base Month Measurement Month of Adjustment September 1999 March 2000 July 1, 2000 March 2000 September 2000 January 1, 2001 Measurement Periods and Effective Dates conforming to the above schedule shall be applicable to periods subsequent to those specified above during which this Article is in effect.
Measurement Periods. The PFS Impact Estimates for the Preterm Birth, Child Injury, and the Healthy Birth Interval PFS Outcome Metrics will compare outcomes for Sample Members who were Randomized to the Intervention Group to those who were Randomized to the Control Group. The PFS Impact Estimate for the Coverage of LIZCs will be measured on results of the Intervention Group only.
Measurement Periods. The PFS Evaluation will include two different measurement periods. During Measurement Period 1, the Independent Evaluator will determine the PFS Impact Estimates for the Preterm Birth and Coverage in LIZCs PFS Outcome Metrics using the subset of the Study Sample Members whose data is observable and available at the time. The PFS Impact Estimates will be used by Children’s Trust to calculate Success Payment 1 pursuant to Annex I. During Measurement Period 2, the Independent Evaluator will determine the PFS Impact Estimates for the Healthy Birth Intervals and Child Injury PFS Outcome Metrics using the subset of the Sample Members whose data is observable and available at the time. These data points will be used by Children’s Trust to calculate Success Payment 2 pursuant to Annex I.
Measurement Periods. Notwithstanding any other provision of the Certificate of Designations, this Agreement, any other Transaction Document, or any other agreement, document or instrument, each and every Measurement Period with regard to any share of Preferred converted by Investor or any affiliate of Investor prior to the Agreement Date will terminate, and the provisions of Section I.G.1.d shall no longer apply with respect to any shares of Preferred converted prior to the Agreement Date. For the avoidance of doubt, the foregoing shall have no affect with regard to any shares of Preferred that are first converted after the Agreement Date.
Measurement Periods. Notwithstanding the provisions of Section I.G.7.k of the Certificate in effect prior to the date of this Agreement, beginning on the Agreement Date and thereafter, the proviso in the definition of Measurement Period will no longer apply, and no Trading Days will be added to what would otherwise have been the end of any Measurement Period for the failure of the Equity Condition in Section I.G.7.h of the Certificate, even if the Measuring Metric is not at least $1.50; and each Investor hereby waives the right to receive any additional shares of Common Stock that might otherwise be due if such Equity Condition were to apply after the Agreement Date, including with respect to any pending Measurement Period.
Measurement Periods. The periods for calculation of the Earn-Out Payments shall be as follows:
Measurement Periods. Year 1: October 1, 2017 – September 30, 2018. Target will provide financial statements for the period Oct 1, 2017 through closing date for Buyer to include in the earnout calculations contained in Schedule 3.4. Year 2: October 1, 2018 – September 30, 2019 Revenue Assumptions: • Revenue measurement is based on US GAAP revenue recognition rules. • Revenues recorded for Target products sold by Buyer will be counted towards the earn-out targets contained in Section 1 of this Schedule 3.4. ***Confidential Treatment Requested 46/67 • Revenues recorded by Target for Buyer products sold by Target will also be counted towards the earn-out targets contained in Section 1 of this Schedule 3.4. • For revenues recognized for products that contain both Buyer and Target technology, an allocation will be made based on the relative value of the related technologies included in the product being sold. Target will be given revenue credit for the proportionate revenues recognized. • If Year 1 revenues exceed the maximum target of […***…] EUR, the excess amount of revenues will be counted towards the revenue target for Year 2. • If Year 2 revenues exceed the maximum target of […***…] EUR, there will be no additional earn-out payment for the excess revenue. • If the revenue for the quarter ending December 31, 2017 exceeds […***…] EUR, then […***…] EUR of the earnout will be paid into the Escrow Account to be released on the first Year anniversary date. The remainder of Year 1 earnout will be then based on the Year 1 targets.
Measurement Periods. Minimum Fixed Charge -------------------- -------------------- Coverage Ratio: --------------- Measurement Periods ending through and including last day of Fiscal Quarter 3 of Fiscal Year 2004: 1.20 to 1.00 Measurement Periods ending last day of Fiscal Year 2004 through and including last day of Fiscal Quarter 3 of Fiscal Year 2005: 1.25 to 1.00 Each Measurement Period ending thereafter: 1.30 to 1.00
Measurement Periods. Each one-year period during the Term (each being a “Measurement Period”) shall begin on the Effective Date or anniversary of the Effective Date, as applicable, and shall end at midnight on the day immediately preceding the next anniversary of the Effective Date. The final day of each Measurement Period shall be referred to as a “Measurement Date.”
Measurement Periods. Baseline Measurement January 1, 2022 through December 31, 2022 Intervention Year January 1, 2023 through December 31, 2023 First Re-measurement January 1, 2024 through December 31, 2024 Second Re-measurement January 1, 2025 through December 31, 2025 Care 1st ACC-RBHA (RBHA Population Only) Baseline Measurement January 1, 2023 through December 31, 2023 Intervention Year January 1, 2024 through December 31, 2024 First Re-measurement January 1, 2025 through December 31, 2025 Second Re-measurement January 1, 2026 through December 31, 2026 Study Question: What is the number and percent, overall and by Contractor, of members with live birth deliveries that 1) received a prenatal care visit in the first trimester, on or before the enrollment start date, or within 42 days of enrollment, and 2) had a postpartum visit on or between 7 and 84 days after delivery? Data Collection Methodology and Validation: Data shall be collected annually by the Contractors for the purposes of this PIP. Contractors shall utilize the hybrid methodology (including all allowable data sources) to determine the indicator rates outlined within the Project Indicators section, in accordance with the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®) technical specifications. Contractor- calculated performance measure (indicator) results, data collection methodology, and data sources will be validated by the External Quality Review Organization (EQRO) in alignment with the Centers for Medicare and Medicaid Services (CMS) External Quality Review (EQR) Protocol 2. Confidentiality Plan AHCCCS, as well as its EQRO and Contractors, maintains compliance with the Health Insurance Portability and Accountability Act (HIPAA) requirements. AHCCCS employees and EQRO staff who analyze data for this project may have access to study data. Member names are never identified or used in AHCCCS reporting; AHCCCS PIP data are used only for the purposes of performing health care operations, conducting oversight of the health care system, or conducting research.
